Canadian cannabis company Tilray entered a $100 million joint venture with beer brewer AB InBev to study non-alcoholic THC and CBD beverages, the companies announced Wednesday.
Shares of Tilray jumped 12 percent after hours.
On Tuesday, Tilray announced a partnership with Novartis unit Sandoz to produce and distribute medical cannabis products. News of the deal sent Tilray shares soaring as much as 22 percent. They fell more than 6 percent Wednesday.
from Top News & Analysis https://ift.tt/2EyoVqd
No comments:
Post a Comment